NASH Management 2021 Update: What Is the Effect of Antidiabetic Medications in T2D/NAFLD? Are PPARs and GLP-1RAs Safe/Efficient Agents? What Are the Benefits of Pioglitazone?

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

NASH Management 2021 Update: What Is the Effect of Antidiabetic Medications in T2D/NAFLD? Are PPARs and GLP-1RAs Safe/Efficient Agents? What Are the Benefits of Pioglitazone?

By Cardiometabolic Health Congress (CMHC) FEATURING Kenneth Cusi

989 views

February 15, 2021

0 Comments

Getting Patients Started with an Obesity Treatment Option for Adults

Feat. E. Lazarus

Getting Patients Started with an Obesity Treatment Option for Adults

Feat. E. Lazarus

The Protein Myth: Our Obsession With Protein and How It Is Killing US

Feat. G. Davis

49:21

Physicians Committee for Responsible Medicine

Health of Vegetarians and Vegans: Findings From EPIC-Oxford and Othe…

Feat. T. J. Key

23:35

Practical Ways to Achieve Targets in Diabetes Care

Is There a Future for HbA1c? (Moving Towards CGM: GMI and TIR)

Feat. I. Hirsch

15:06

Robert Busch

GLP-1/GIP Update: Stay Tuned... The Best is Yet to Come!!

37:21

University of Colorado Department of Medicine

Evidence that Obesity and Diabetes are Driven by a Diet-Induced Biol…

Feat. R. Johnson

12:26

Juan Frias

SURPASS 2: Tirzepatide Versus Once-Weekly Semaglutide

15:33

Ken Fujioka

Could GLP-1's be a 'Game Changer' For Weight Loss? Ca…

18:46

Houston Methodist Hospital

MAFLD: What Is It?

Feat. D. Victor

17:44

Rita Jermyn

SGLT2 Inhibitors: For Heart Failure, Diabetes, and Renal Disease

26:32

Practical Ways to Achieve Targets in Diabetes Care

Metabolic Surgery vs. Pharmacotherapy for Treatment of Obesity

Feat. S. Nissen

26:49

Diana Isaacs

Tirzepatide Updates

44:43

Jason Fung

Type 2 Diabetes Aetiology and Reversibility

23:21

Practical Ways to Achieve Targets in Diabetes Care

TIR vs. A1c: Q&A/ Panel Discussion

Feat. J. Skyler, G. Aleppo, T. Danne, L. Barbour

33:23

Keck School of Medicine of USC

Effects of Low Calorie and Alternative Sweeteners Across the Lifespa…

Feat. M. Goran

43:23

MedNews Week

Best Practices In Managing NAFLD / NASH

Feat. D. Bernstein

10:02

Emory Diabetes Education Training Academy

Insulin Treatment in Patients with Type 2 Diabetes: When to Use Comb…

Feat. G. Umpierrez

32:34

Cardiometabolic Health Congress (CMHC)

Long-Term Cardiometabolic Risk in PCOS: How to Diagnose? Is Obesity …

Feat. A. Dokras-Jagasia

28:31

Practical Ways to Achieve Targets in Diabetes Care

Hybrid Closed Loop (HCL) Systems

Feat. E. Cengiz

37:10

Diana Isaacs

Clinical Pearls & Updates on Incretins: The Diabetes Drugs Takin…

21:10

Trevor Steward

Login

Login

Join VuMedi

NASH Management 2021 Update: What Is the Effect of Antidiabetic Medications in T2D/NAFLD? Are PPARs and GLP-1RAs Safe/Efficient Agents? What Are the Benefits of Pioglitazone?

Related Content